Clinical Trial: BALANCE+ Vanguard Phase
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Gram-negative Bacteremia
Study Type: INTERVENTIONAL
Official Title: BALANCE+: A Platform Trial for Gram Negative Bloodstream Infections
Brief Summary:
The goal of the BALANCE+ clinical trial is to transform random care to randomized care for patients with Gram negative bloodstream infections to inform best treatment approaches and optimize outcomes.BALANCE+, a perpetual platform trial, will efficiently answer multiple questions that are important for hospitalized patients with Gram negative bloodstream infections.
Read more